Affordable Access

Access to the full text

Airway Microbiome and Serum Metabolomics Analysis Identify Differential Candidate Biomarkers in Allergic Rhinitis

  • Yuan, Yuze1
  • Wang, Chao1
  • Wang, Guoqiang1
  • Guo, Xiaoping1
  • Jiang, Shengyu1
  • Zuo, Xu1
  • Wang, Xinlei1
  • Hsu, Alan Chen-Yu2, 3, 4
  • Qi, Mingran1
  • Wang, Fang1
  • 1 Department of Pathogeny Biology, College of Basic Medical Sciences, Jilin University, Changchun , (China)
  • 2 Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, NSW , (Australia)
  • 3 School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW , (Australia)
  • 4 Programme in Emerging Infectious Diseases, Duke - National University of Singapore (NUS) Medical School, Singapore , (Singapore)
Published Article
Frontiers in Immunology
Frontiers Media SA
Publication Date
Jan 05, 2022
DOI: 10.3389/fimmu.2021.771136
  • Immunology
  • Original Research


Allergic rhinitis (AR) is a common heterogeneous chronic disease with a high prevalence and a complex pathogenesis influenced by numerous factors, involving a combination of genetic and environmental factors. To gain insight into the pathogenesis of AR and to identity diagnostic biomarkers, we combined systems biology approach to analyze microbiome and serum composition. We collected inferior turbinate swabs and serum samples to study the microbiome and serum metabolome of 28 patients with allergic rhinitis and 15 healthy individuals. We sequenced the V3 and V4 regions of the 16S rDNA gene from the upper respiratory samples. Metabolomics was used to examine serum samples. Finally, we combined differential microbiota and differential metabolites to find potential biomarkers. We found no significant differences in diversity between the disease and control groups, but changes in the structure of the microbiota. Compared to the HC group, the AR group showed a significantly higher abundance of 1 phylum (Actinobacteria) and 7 genera (Klebsiella, Prevotella and Staphylococcus, etc.) and a significantly lower abundance of 1 genus (Pelomonas). Serum metabolomics revealed 26 different metabolites (Prostaglandin D2, 20-Hydroxy-leukotriene B4 and Linoleic acid, etc.) and 16 disrupted metabolic pathways (Linoleic acid metabolism, Arachidonic acid metabolism and Tryptophan metabolism, etc.). The combined respiratory microbiome and serum metabolomics datasets showed a degree of correlation reflecting the influence of the microbiome on metabolic activity. Our results show that microbiome and metabolomics analyses provide important candidate biomarkers, and in particular, differential genera in the microbiome have also been validated by random forest prediction models. Differential microbes and differential metabolites have the potential to be used as biomarkers for the diagnosis of allergic rhinitis.

Report this publication


Seen <100 times